John P. Houston - Concepedia

Author

John P. Houston

Also Known As

Borghuis, VAJ, J HOUSTON, J P Houston, J. Houston, J. P. Houston, J.P. Houston, JOHN P. HOUSTON, John Houston, John P Houston, John P. Houston

217

Publications

Citations

H-Index

148

Concepts

All Affiliations

Eli Lilly (United States)The University of Texas Health Science Center at San Antonio University of California, Los Angeles Massachusetts General Hospital Indiana University – Purdue University Indianapolis

About

John P. Houston is an author at Eli Lilly (United States) specializing in medicine, psychiatry, and social sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Education	9	9	258
2	Language Studies	5	5	165
3	Health Sciences	4	4	138
4	Arts	2	2	59
5	Management	1	1	13

John P. Houston

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Onset and Early Behavioral Effects of Pharmacologically Different Antidepressants and Placebo in Depression Martin M. Katz, Janet L. Tekell, Charles L. Bowden, Neuropsychopharmacology Psychotropic MedicationPsychopharmacologyMental HealthPharmacologically Different AntidepressantsSocial Sciences	2003	248
Measurement of verbal relatedness: An idiographic approach. Bertram E. Garskof, John P. Houston Psychological Review LinguisticsPsycholinguisticsVerbal RelatednessLanguage StudiesSpeech Perception	1963	113
Failure to Replicate Genetic Associations with Antidepressant Treatment Response in Duloxetine-Treated Patients Roy H. Perlis, Bonnie A. Fijal, Sweta Dharia, Biological Psychiatry PsychiatryMedicineGeneticsPsychotropic MedicationGenetic Epidemiology	2010	89
Differential Efficacy of Olanzapine and Lithium in Preventing Manic or Mixed Recurrence in Patients With Bipolar I Disorder Based on Number of Previous Manic or Mixed Episodes Terence A. Ketter, John P. Houston, David Adams, The Journal of Clinical Psychiatry	2006	85
Creativity and the need for novelty. John P. Houston, Sarnoff A. Mednick Journal of Abnormal & Social Psychology Creative WritingCreativityCreative ThinkingDesign ThinkingEducation	1963	80
Variation in Catechol-O-Methyltransferase Is Associated with Duloxetine Response in a Clinical Trial for Major Depressive Disorder Roy H. Perlis, Bonnie A. Fijal, David H. Adams, Biological Psychiatry Molecular PharmacologyPsychiatryMood SymptomMedicinePsychotropic Medication	2008	78
Reduction of platelet serotonin content in depressed patients treated with either paroxetine or desipramine Martin A. Javors, John P. Houston, Janet L. Tekell, The International Journal of Neuropsychopharmacology Psychotropic MedicationPsychopharmacologyDepressed PatientsPharmacotherapyExperimental Pharmacology	2000	78
Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression Eileen Brown, David L. Dünner, Susan L. McElroy, The International Journal of Neuropsychopharmacology	2008	73
Cerebrospinal fluid HVA, central brain atrophy, and clinical state in schizophrenia John P. Houston, James W. Maas, Charles L. Bowden, Psychiatry Research Clinical StateCerebrospinal Fluid HvaNeuropsychiatryClinical NeuroscienceCerebrospinal Fluid	1986	71
Candidate-gene association analysis of response to risperidone in African-American and white patients with schizophrenia Bonnie A. Fijal, Bruce J. Kinon, Shitij Kapur, The Pharmacogenomics Journal PsychiatryPsychotic DisorderPsychotropic MedicationPsychiatric GeneticsGenetic Epidemiology	2009	66

Page 1